Application of advances in molecular biology to the treatment of brain tumors.

被引：9
作者：
Takeshima H. [1 ]
Sawamura Y. [1 ]
Gilbert M.R. [1 ]
Van Meir EG [1 ]
机构：
[1] Department of Neurosurgery, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuraga-oka, Kagoshima
来源：
Current Oncology Reports | 2000年 / 2卷 / 5期
关键词：
Brain Tumor; Medulloblastoma; Malignant Glioma; Adenomatous Polyposis Coli; Thymidine Kinase;
D O I：
10.1007/s11912-000-0062-4
中图分类号：
学科分类号：
摘要：
Recent advances in molecular biology have substantially improved our understanding of the molecular genetics of primary brain neoplasms. Soon each histopathologic category of glioma will be further divided into subgroups according to similar genetic background, gene expression profile, and similarity of biologic responses to radiotherapy or chemotherapy. Identification of key molecules that are specifically altered in neoplastic cells will provide candidate molecular targets for tumor treatment. Novel therapeutic tools for targeting tumor cells, such as viral vectors for gene therapy, have been created. In the near future, the accumulation of new knowledge in brain tumor biology and genetics, combined with rational drug design, will revolutionize the treatment of malignant gliomas, which are among the most lethal human cancers.
引用
收藏
页码：425 / 433
页数：8
相关论文
共 148 条
[1]  
Daumas DC(1988)Grading of astrocytomas. A simple and reproducible method Cancer 62 2152-2165
[2]  
Scheithauer B(1997)Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies Clin Cancer Res 3 523-530
[3]  
O’Fallon J(1994)Platelet-derived growth factor receptor signals J Biol Chem 269 32023-32026
[4]  
Watanabe K(1994)Deletion of p16 and p15 genes in brain tumors Cancer Res 54 6353-6358
[5]  
Sata K(1998)ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways Cell 92 725-734
[6]  
Biernat W(1997)Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat Genet 15 356-362
[7]  
Claesson Welsh L(1997)Loss of DCC expression and glioma progression Cancer Res 57 382-386
[8]  
Jen J(1940)Cerebral astrocytomas and their derivatives Am J Cancer 40 159-198
[9]  
Harper JW(1994)Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors J Neurosurg 81 427-436
[10]  
Bigner SH(1994)Molecular genetic analysis of oligodendroglial tumors shows prefential allelic deletions on 19q and 1p Am J Pathol 145 1175-1190
12345678910